Literature DB >> 22278734

The association between insulin and low-density lipoprotein receptors.

Gopalakrishnan Ramakrishnan1, Albina Arjuman, Shilpa Suneja, Chandana Das, Nimai C Chandra.   

Abstract

The insulin receptor (IR) and low-density lipoprotein receptor (LDLR) maintain glucose and lipid metabolism, respectively. Diabetes is associated with increased blood glucose, dyslipidaemia and increased risk of atherosclerosis. We hypothesise that interactions between IR and LDLR play a role in the atherosclerotic process in subjects with diabetes. Therefore, in this work we studied potential interactions between these two receptors. Our data show an intracellular and surface membrane-bound co-association of IR and LDLR. The co-association makes LDLR functionally poor in clearing extra-cellular LDL particles. A short 10 min exposure of cells to insulin disrupts the association between the two receptors and generates LDLR with higher LDL clearing activity without any change in protein expression. This co-association of LDLR with IR and their dissociation by insulin may be an important part of the regulatory mechanism of the normal physiological receptor function in a biological system. Modulation of receptor co-association is potentially a therapeutic target to reduce cardiovascular risk, and further studies are needed to investigate this possibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278734     DOI: 10.1177/1479164111430243

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  8 in total

1.  Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.

Authors:  Lance A Johnson; Reid H J Olsen; Louise S Merkens; Andrea DeBarber; Robert D Steiner; Patrick M Sullivan; Nobuyo Maeda; Jacob Raber
Journal:  Neurobiol Dis       Date:  2014-01-09       Impact factor: 5.996

2.  DNA methylation and expression profiles of placenta and umbilical cord blood reveal the characteristics of gestational diabetes mellitus patients and offspring.

Authors:  Sha Lu; Jiahao Wang; Nisile Kakongoma; Wen Hua; Jiahui Xu; Yunfei Wang; Shutao He; Hongcang Gu; Jiantao Shi; Wensheng Hu
Journal:  Clin Epigenetics       Date:  2022-05-23       Impact factor: 7.259

3.  Cholesterol-related gene variants are associated with diabetes in coronary artery disease patients.

Authors:  Aybike Sena Ozuynuk; Aycan Fahri Erkan; Berkay Ekici; Nihan Erginel-Unaltuna; Neslihan Coban
Journal:  Mol Biol Rep       Date:  2021-05-21       Impact factor: 2.316

4.  Cholesterol Homeostasis in Isolated Lymphocytes: a Differential Correlation Between Male Control and Chronic Lymphocytic Leukemia Subjects

Authors:  Shrimanjunath Sankanagoudar; Govind Singh; Manaranjan Mahapatra; Lalit Kumar; Nimai Chand Chandra
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

5.  Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study.

Authors:  Yu Zhang; He He; Yu-Ping Zeng; Li-Dan Yang; Dan Jia; Zhen-Mei An; Wei-Guo Jia
Journal:  Lipids Health Dis       Date:  2020-06-11       Impact factor: 3.876

6.  The relationships between FLAIS, a novel insulin sensitivity index, and cardiovascular risk factors in a population-based study.

Authors:  Monika Karczewska-Kupczewska; Agnieszka Nikołajuk; Marcin Kondraciuk; Zofia Stachurska; Marlena Dubatówka; Anna Szpakowicz; Marek Strączkowski; Irina Kowalska; Karol Kamiński
Journal:  Cardiovasc Diabetol       Date:  2022-04-19       Impact factor: 8.949

Review 7.  Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect.

Authors:  Dong-Yong Hong; Dong-Hun Lee; Ji-Young Lee; Eun-Chae Lee; Sang-Won Park; Man-Ryul Lee; Jae-Sang Oh
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

8.  Role of leptin on the expression of low density lipoprotein receptor.

Authors:  Naval Kishor Yadav; Albina Arjuman; Nimai C Chandra
Journal:  Indian J Med Res       Date:  2014-10       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.